{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:32:05Z","timestamp":1786365125036,"version":"build-2736575974"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003010","name":"Ege \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004410","name":"T\u00dcB\u0130TAK","doi-asserted-by":"publisher","award":["218S986"],"award-info":[{"award-number":["218S986"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004410","name":"T\u00dcB\u0130TAK","doi-asserted-by":"publisher","award":["218S987"],"award-info":[{"award-number":["218S987"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004410","name":"T\u00dcB\u0130TAK","doi-asserted-by":"publisher","award":["218S988"],"award-info":[{"award-number":["218S988"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.intimp.2024.112787","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T07:58:19Z","timestamp":1722412699000},"page":"112787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Insights from CD71 presentation and serum lipid peroxidation in myasthenia gravis \u2013 A small cohort study"],"prefix":"10.1016","volume":"140","author":[{"given":"Sinem","family":"Tun\u00e7er \u00c7a\u011flayan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birsen","family":"Elibol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feride","family":"Severcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"Basar Gursoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bedile Irem","family":"Tiftikcioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep","family":"Gungordu Dalar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ceren","family":"Celik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse Suna","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevin\u00e7","family":"Kara\u00e7am","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.112787_b0005","doi-asserted-by":"crossref","DOI":"10.3390\/cells8070671","article-title":"Myasthenia gravis: Pathogenic effects of autoantibodies on neuromuscular architecture","author":"Koneczny","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2024.112787_b0010","doi-asserted-by":"crossref","unstructured":"A. Jayam Trouth, A. Dabi, N. Solieman, M. Kurukumbi, J. Kalyanam. (2012) Myasthenia Gravis: A Review, Autoimmune Dis. 2012 1\u201310. doi: 10.1155\/2012\/874680.","DOI":"10.1155\/2012\/874680"},{"key":"10.1016\/j.intimp.2024.112787_b0015","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s12883-023-03406-0","article-title":"Female sex and overweight are associated with a lower quality of life in patients with myasthenia gravis: a single center cohort study","volume":"23","author":"Wilcke","year":"2023","journal-title":"BMC Neurol."},{"key":"10.1016\/j.intimp.2024.112787_b0020","doi-asserted-by":"crossref","unstructured":"H. Wang, Z. Xiong. (2017) Myasthenia Gravis, in: Anesthesiology, Springer International Publishing, Cham: pp. 155\u2013160. doi: 10.1007\/978-3-319-50141-3_22.","DOI":"10.1007\/978-3-319-50141-3_22"},{"key":"10.1016\/j.intimp.2024.112787_b0025","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.3390\/brainsci13091286","article-title":"Diagnosis and management of seronegative myasthenia gravis: lights and shadows","volume":"13","author":"Vinciguerra","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.intimp.2024.112787_b0030","article-title":"Autoimmune thyroid disease and myasthenia gravis: a study bidirectional Mendelian randomization","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.intimp.2024.112787_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.593431","article-title":"Immunoregulatory cells in myasthenia gravis","author":"Wu","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.intimp.2024.112787_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00809","article-title":"CD4+ T cells of myasthenia gravis patients are characterized by increased IL-21, IL-4, and IL-17A productions and higher presence of PD-1 and ICOS","author":"\u00c7ebi","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112787_b0045","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-3083.1995.tb03680.x","article-title":"Suppression of experimental autoimmune myasthenia gravis after CD8 depletion is associated with decreased IFN-\u03b3 and IL-4","volume":"42","author":"Zhang","year":"1995","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.intimp.2024.112787_b0050","doi-asserted-by":"crossref","DOI":"10.1084\/jem.184.2.349","article-title":"Both CD4+ and CD8+ T cells are essential to induce experimental autoimmune myasthenia gravis","author":"Zhang","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2024.112787_b0055","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2165\/11593300-000000000-00000","article-title":"Treatment of myasthenia gravis","volume":"31","author":"Maggi","year":"2011","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.intimp.2024.112787_b0060","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1007\/s00415-022-11023-z","article-title":"Seronegative myasthenic crisis: a multicenter analysis","volume":"269","author":"Mergenthaler","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.intimp.2024.112787_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2022.09.002","article-title":"The effectiveness and side effects of pyridostigmine in the treatment of myasthenia gravis: a cross-sectional study","author":"Remijn-Nelissen","year":"2022","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.intimp.2024.112787_b0070","doi-asserted-by":"crossref","DOI":"10.1530\/endoabs.70.AEP934","article-title":"Myasthenia gravis associated with Graves\u2019 disease: about three cases","author":"Majdoub","year":"2020","journal-title":"Endocr. Abstr."},{"key":"10.1016\/j.intimp.2024.112787_b0075","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/mus.20030","article-title":"Clinical evaluation and management of myasthenia gravis","volume":"29","author":"Keesey","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.intimp.2024.112787_b0080","first-page":"716","article-title":"Myasthenia gravis after kidney transplantation","volume":"36","author":"Nieto-Rios","year":"2016","journal-title":"Nefrologia"},{"key":"10.1016\/j.intimp.2024.112787_b0085","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.27826","article-title":"Seronegative ocular myasthenia gravis in an older woman with transient dizziness and diplopia","author":"Yoshioka","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.intimp.2024.112787_b0090","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2022-000241","article-title":"New and emerging treatments for myasthenia gravis","author":"DeHart-McCoyle","year":"2023","journal-title":"BMJ Med."},{"key":"10.1016\/j.intimp.2024.112787_b0095","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000324915","article-title":"Repetitive nerve stimulation of facial and hypothenar muscles: relative sensitivity in different myasthenia gravis subgroups","volume":"65","author":"Zambelis","year":"2011","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.intimp.2024.112787_b0100","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10112235","article-title":"Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations","author":"Dresser","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2024.112787_b0105","doi-asserted-by":"crossref","DOI":"10.1002\/mus.26104","article-title":"Gender and quality of life in myasthenia gravis patients from the myasthenia gravis foundation of America registry","author":"Lee","year":"2018","journal-title":"Muscle and Nerve"},{"key":"10.1016\/j.intimp.2024.112787_b0110","doi-asserted-by":"crossref","DOI":"10.1001\/archneur.62.11.1689","article-title":"Treatment of myasthenia gravis exacerbation with intravenous immunoglobulin","author":"Gajdos","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.intimp.2024.112787_b0115","doi-asserted-by":"crossref","first-page":"597","DOI":"10.22237\/jmasm\/1257035100","article-title":"New effect size rules of thumb","volume":"8","author":"Sawilowsky","year":"2009","journal-title":"J. Mod. Appl. Stat. Methods"},{"key":"10.1016\/j.intimp.2024.112787_b0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5799\/jmid.396290","article-title":"Correlation between serum Calcium levels and smear grading among the pulmonary tuberculosis patients","volume":"08","author":"Chandra","year":"2018","journal-title":"J. Microbiol. Infect. Dis."},{"key":"10.1016\/j.intimp.2024.112787_b0125","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12967-024-04965-7","article-title":"An angel or a devil? Current view on the role of CD8+ T cells in the pathogenesis of myasthenia gravis","volume":"22","author":"Peng","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.intimp.2024.112787_b0130","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000203583","article-title":"CD8 T cell immune signatures in autoimmune myasthenia gravis (N6.001)","volume":"100","author":"Li","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2024.112787_b0135","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1983.tb00707.x","article-title":"Disease associations with complotypes, supratypes and haplotypes","volume":"70","author":"Dawkins","year":"1983","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2024.112787_b0140","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12916-021-02034-0","article-title":"Metagenome-wide association study of gut microbiome revealed potential microbial marker set for diagnosis of pediatric myasthenia gravis","volume":"19","author":"Liu","year":"2021","journal-title":"BMC Med."},{"key":"10.1016\/j.intimp.2024.112787_b0145","doi-asserted-by":"crossref","DOI":"10.3390\/nu14081647","article-title":"Exploring the gut microbiome in myasthenia gravis","author":"Thye","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.intimp.2024.112787_b0150","doi-asserted-by":"crossref","DOI":"10.2119\/molmed.2015.00232","article-title":"Genome-wide association study of late-onset myasthenia gravis: confirmation of TNFRSF11A and identification of ZBTB10 and three distinct HLA associations","author":"Seldin","year":"2015","journal-title":"Mol. Med."},{"key":"10.1016\/j.intimp.2024.112787_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2017.00169","article-title":"Autoimmune thyroiditis and myasthenia gravis","author":"Lopomo","year":"2017","journal-title":"Front. Endocrinol. (lausanne)."},{"key":"10.1016\/j.intimp.2024.112787_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01301","article-title":"Add-on Pyridostigmine enhances CD4+ T-cell recovery in HIV-1-infected immunological non-responders: a proof-of-concept study","author":"Vald\u00e9s-Ferrer","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112787_b0165","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0163-7258(99)00071-6","article-title":"Extraneuronal cholinergic system in lymphocytes","volume":"86","author":"Kawashima","year":"2000","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2024.112787_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphs.2017.05.002","article-title":"Physiological functions of the cholinergic system in immune cells","author":"Fujii","year":"2017","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2024.112787_b0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01085","article-title":"Expression and function of the cholinergic system in immune cells","author":"Fujii","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112787_b0180","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.taap.2009.10.020","article-title":"Nicotine-mediated signals modulate cell death and survival of T lymphocytes","volume":"242","author":"Oloris","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112787_b0185","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s42003-020-01294-5","article-title":"Transferrin receptor 1 is a cellular receptor for human heme-albumin","volume":"3","author":"Jennifer","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.intimp.2024.112787_b0190","doi-asserted-by":"crossref","DOI":"10.3109\/08916939908993860","article-title":"Cell-surface expression of lymphocyte activation markers in myasthenia gravis","author":"Ragheb","year":"1999","journal-title":"Autoimmunity"},{"key":"10.1016\/j.intimp.2024.112787_b0195","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jneuroim.2013.09.006","article-title":"Disturbed B cell subpopulations and increased plasma cells in myasthenia gravis patients","volume":"264","author":"Kohler","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.intimp.2024.112787_b0200","doi-asserted-by":"crossref","DOI":"10.1002\/mus.25973","article-title":"B cells in the pathophysiology of myasthenia gravis","author":"Yi","year":"2018","journal-title":"Muscle and Nerve"},{"key":"10.1016\/j.intimp.2024.112787_b0205","article-title":"The longevity of the humoral immune response \u2013 survival of long-lived plasma cells","volume":"2","author":"Liew","year":"2012","journal-title":"Akademeia"},{"key":"10.1016\/j.intimp.2024.112787_b0210","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.nmd.2014.05.001","article-title":"The decreased expression of thioredoxin-1 in brain of mice with experimental autoimmune myasthenia gravis","volume":"24","author":"Chen","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.intimp.2024.112787_b0215","article-title":"The relationship between serum iron levels and AChR-Ab and IL-6 in patients with myasthenia gravis","author":"Huang","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2024.112787_b0220","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.1060204","article-title":"Iron metabolism patterns in non-anemic patients with myasthenia gravis: a cross-sectional and follow-up study","volume":"13","author":"Li","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.intimp.2024.112787_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2023.578015","article-title":"Iron metabolism in non-anemic myasthenia gravis patients: a cohort study","volume":"375","author":"Li","year":"2023","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.intimp.2024.112787_b0230","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abq0178","article-title":"Elevated transferrin receptor impairs T cell metabolism and function in systemic lupus erythematosus","author":"Voss","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.intimp.2024.112787_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-023-04664-9","article-title":"Anaplastic thyroid cancer cells reduce CD71 levels to increase iron overload tolerance","volume":"21","author":"D\u2019Aprile","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.intimp.2024.112787_b0240","doi-asserted-by":"crossref","DOI":"10.3390\/ph11040113","article-title":"Links between iron and lipids: implications in some major human diseases","author":"Rockfield","year":"2018","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.intimp.2024.112787_b0245","article-title":"Lipid metabolism and ferroptosis","author":"Lee","year":"2021","journal-title":"Biology (Basel)."},{"key":"10.1016\/j.intimp.2024.112787_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104382","article-title":"Metabolism-dependent ferroptosis promotes mitochondrial dysfunction and inflammation in CD4+ T lymphocytes in HIV-infected immune non-responders","volume":"86","author":"Xiao","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.intimp.2024.112787_b0255","doi-asserted-by":"crossref","DOI":"10.3892\/etm.2023.12067","article-title":"Ferroptosis: a potential therapeutic target in autoimmune disease (Review)","author":"Shen","year":"2023","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.intimp.2024.112787_b0260","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.916664","article-title":"Ferroptosis and autoimmune diseases","volume":"13","author":"Lai","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112787_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2017.01.019","article-title":"Oxidative modifications of blood serum proteins in myasthenia gravis","author":"Adamczyk-Sowa","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.intimp.2024.112787_b0270","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1113\/jphysiol.2011.214007","article-title":"Reactive oxygen species inactivate neuronal nicotinic acetylcholine receptors through a highly conserved cysteine near the intracellular mouth of the channel: implications for diseases that involve oxidative stress","volume":"590","author":"Krishnaswamy","year":"2012","journal-title":"J. Physiol."},{"key":"10.1016\/j.intimp.2024.112787_b0275","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3109\/00207454.2015.1134526","article-title":"Low antioxidant status of serum bilirubin, uric acid, albumin and creatinine in patients with myasthenia gravis","volume":"126","author":"Yang","year":"2016","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.intimp.2024.112787_b0280","article-title":"Antioxidant status of bilirubin and uric acid in patients with myasthenia gravis","author":"Peng","year":"2011","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.intimp.2024.112787_b0285","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000343360","article-title":"Acetylcholine Attenuates hypoxia\/ reoxygenation-induced mitochondrial and cytosolic ROS formation in H9c2 Cells via M2 acetylcholine receptor","volume":"31","author":"Miao","year":"2013","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.intimp.2024.112787_b0290","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1111\/j.1572-0241.1998.536_e.x","article-title":"Influence of topically and systemically active steroids on circulating leukocytes in Crohn\u2019s disease","volume":"93","author":"Tillinger","year":"1998","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.intimp.2024.112787_b0295","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1038\/s41598-024-52539-w","article-title":"Registered trials on novel therapies for myasthenia gravis: a cross-sectional study on ClinicalTrials.gov","volume":"14","author":"Li","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2024.112787_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2023.111793","article-title":"Sex differences in neuromuscular disorders","volume":"211","author":"Vinciguerra","year":"2023","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.intimp.2024.112787_b0305","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/mus.27331","article-title":"Gender differences in clinical outcomes in myasthenia gravis: a prospective cohort study","volume":"64","author":"Thomsen","year":"2021","journal-title":"Muscle Nerve"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924013080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924013080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:02:13Z","timestamp":1786363333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924013080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":61,"alternative-id":["S1567576924013080"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112787","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights from CD71 presentation and serum lipid peroxidation in myasthenia gravis \u2013 A small cohort study","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112787","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112787"}}